These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6489403)

  • 1. Cerebrospinal fluid neurophysins in affective illness and in schizophrenia.
    Linkowski P; Geenen V; Kerkhofs M; Mendlewicz J; Legros JJ
    Eur Arch Psychiatry Neurol Sci; 1984; 234(3):162-5. PubMed ID: 6489403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics.
    Legros JJ; Gazzotti C; Carvelli T; Franchimont P; Timsit-Berthier M; von Frenckell R; Ansseau M
    Psychoneuroendocrinology; 1992 Nov; 17(6):611-7. PubMed ID: 1287681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma vasopressin and human neurophysins in physiological and pathological states associated with changes in vasopressin secretion.
    Pullan PT; Clappison BH; Johnston CI
    J Clin Endocrinol Metab; 1979 Oct; 49(4):580-7. PubMed ID: 479348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin, vasopressin, and estrogen-stimulated neurophysin: daily patterns of concentration in cerebrospinal fluid.
    Perlow MJ; Reppert SM; Artman HA; Fisher DA; Self SM; Robinson AG
    Science; 1982 Jun; 216(4553):1416-8. PubMed ID: 7201163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurophysins as markers of vasopressin and oxytocin release. A study in carcinoma of the lung.
    Legros JJ; Geenen V; Carvelli T; Martens H; Andre M; Corhay JL; Radermecker M; Zangerle PF; Sassolas G; Gharib C
    Horm Res; 1990; 34(3-4):151-5. PubMed ID: 1966564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated cerebrospinal fluid protein in men with unipolar or bipolar depression.
    Samuelson SD; Winokur G; Pitts AF
    Biol Psychiatry; 1994 Apr; 35(8):539-44. PubMed ID: 8038297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmatic vasopressin neurophysin in depression: basic levels and relations with HPA axis.
    Laruelle M; Seghers A; Goffinet S; Bouchez S; Legros JJ
    Biol Psychiatry; 1990 Jun; 27(11):1249-63. PubMed ID: 2354230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid vasopressin--changes in depression.
    Gjerris A; Hammer M; Vendsborg P; Christensen NJ; Rafaelsen OJ
    Br J Psychiatry; 1985 Dec; 147():696-701. PubMed ID: 3938307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in depressive illness is not associated with altered release of neurophysins over a course of ECT.
    Scott AI; Shering PA; Legros JJ; Whalley LJ
    Psychiatry Res; 1991 Jan; 36(1):65-73. PubMed ID: 2017524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased basal plasma vasopressin-neurophysin in mania.
    Legros JJ; Ansseau M
    Horm Res; 1989; 31(1-2):55-8. PubMed ID: 2722139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid vasopressin in neurological and psychiatric disorders.
    Sørensen PS; Gjerris A; Hammer M
    J Neurol Neurosurg Psychiatry; 1985 Jan; 48(1):50-7. PubMed ID: 3973621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of human neurophysin production in Alzheimer's disease: preliminary observations.
    North WG; Harbaugh R; Reeder T
    Neurobiol Aging; 1992; 13(2):261-5. PubMed ID: 1522943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid somatostatin and psychiatric illness.
    Rubinow DR
    Biol Psychiatry; 1986 Apr; 21(4):341-65. PubMed ID: 2869790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls.
    Pitts AF; Samuelson SD; Meller WH; Bissette G; Nemeroff CB; Kathol RG
    Biol Psychiatry; 1995 Sep; 38(5):330-5. PubMed ID: 7495928
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypothalamoneuropituitary activation during vasodilatator perfusion in normal individuals (author's transl)].
    Smitz S; Waucquez JL; Louis F; Legros JJ
    Acta Psychiatr Belg; 1980; 80(5):762-74. PubMed ID: 7234460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF beta-endorphin-immunoreactivity in normal, schizophrenic, depressed, manic and anorexic subjects.
    Gerner RH; Sharp B
    Brain Res; 1982 Apr; 237(1):244-7. PubMed ID: 6280804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa.
    Gerner RH; Hare TA
    Am J Psychiatry; 1981 Aug; 138(8):1098-101. PubMed ID: 7258390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF prostaglandin levels in depressed and schizophrenic patients.
    Linnoila M; Whorton AR; Rubinow DR; Cowdry RW; Ninan PT; Waters RN
    Arch Gen Psychiatry; 1983 Apr; 40(4):405-6. PubMed ID: 6838321
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebrospinal fluid prostaglandin E in depression, mania, and schizophrenia compared to normals.
    Gerner RH; Merrill JE
    Biol Psychiatry; 1983 May; 18(5):565-9. PubMed ID: 6860728
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls.
    Beckmann H; Lang RE; Gattaz WF
    Psychoneuroendocrinology; 1985; 10(2):187-91. PubMed ID: 4034849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.